Meridiem Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261M Sell
979,371
-47,523
-5% -$12.9M 6.67% 3
2025
Q4
$258M Sell
1,026,894
-30,431
-3% -$8.08M 5.44% 8
2025
Q3
$304M Sell
1,057,325
-11,643
-1% -$3.12M 5.81% 6
2025
Q2
$280M Sell
1,068,968
-197,720
-16% -$48.1M 5.1% 10
2025
Q1
$295M Buy
1,266,688
+55,374
+5% +$13.4M 5.39% 7
2024
Q4
$278M Sell
1,211,314
-6,246
-0.5% -$1.43M 4.97% 9
2024
Q3
$272M Sell
1,217,560
-7,850
-0.6% -$1.73M 4.84% 11
2024
Q2
$249M Buy
1,225,410
+49,240
+4% +$10M 4.68% 13
2024
Q1
$257M Buy
1,176,170
+35,870
+3% +$7.9M 5.04% 13
2023
Q4
$259M Buy
1,140,300
+279,628
+32% +$58.7M 5.59% 8
2023
Q3
$173M Sell
860,672
-139,403
-14% -$29.4M 4.63% 12
2023
Q2
$207M Buy
1,000,075
+3,343
+0.3% +$649K 5.34% 7
2023
Q1
$196M Buy
996,732
+9,630
+1% +$1.98M 5.52% 7
2022
Q4
$200M Buy
987,102
+18,311
+2% +$3.58M 6.19% 6
2022
Q3
$171M Sell
968,791
-132,288
-12% -$27.1M 5.78% 4
2022
Q2
$222M Buy
1,101,079
+162,109
+17% +$34.6M 6.1% 3
2022
Q1
$213M Buy
938,970
+151,999
+19% +$35.7M 6.01% 4
2021
Q4
$212M Sell
786,971
-22,841
-3% -$5.65M 6.41% 3
2021
Q3
$196M Sell
809,812
-3,290
-0.4% -$829K 6.63% 4
2021
Q2
$193M Buy
813,102
+13,369
+2% +$3.05M 6.99% 3
2021
Q1
$175M Sell
799,733
-69,499
-8% -$13.9M 7.05% 3
2020
Q4
$152M Buy
+869,232
New +$150M 7.95% 4

Other funds holding LH

Meridiem Investment Management's LH Position: Q1 2026 in Review

Meridiem Investment Management reduced its Labcorp (LH) stake by 4.6% in Q1 2026, selling an estimated $12.9M and leaving 979,371 shares worth $261M. The position accounts for 6.67% of the portfolio, ranked #3.

Meridiem Investment Management first reported a position in LH in Q4 2020 and has held it in 22 quarters since. The position peaked at $304M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Meridiem Investment Management held 979,371 shares of Labcorp worth $261M as of Q1 2026.
  • Meridiem Investment Management sold 47,523 Labcorp shares in Q1 2026, an estimated $12.9M.
  • Labcorp made up 6.67% of Meridiem Investment Management's portfolio in Q1 2026, its #3 holding.
  • Meridiem Investment Management first reported a position in Labcorp in Q4 2020 and has held it in 22 quarters since.
  • Meridiem Investment Management's Labcorp position peaked at $304M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Meridiem Investment Management's 13F filing for Q1 2026, filed 12 May 2026.